Variant | DSI v | DPI v | Chr | Position | Consequence | Alleles | Class | AF EXOME | AF GENOME | Disease | Disease Class | Score vda | EI vda | N. PMIDs | First Ref. | Last Ref. | ||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
0.732 | 0.160 | 21 | 46606442 | upstream gene variant | G/A | snv | 0.50 |
|
Mental Disorders | 0.020 | 1.000 | 2 | 2007 | 2011 | |||||||
|
0.732 | 0.160 | 21 | 46606442 | upstream gene variant | G/A | snv | 0.50 |
|
Mental Disorders | 0.020 | 1.000 | 2 | 2007 | 2011 | |||||||
|
0.732 | 0.160 | 21 | 46606442 | upstream gene variant | G/A | snv | 0.50 |
|
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Mental Disorders | 0.020 | 1.000 | 2 | 2007 | 2011 | |||||||
|
0.732 | 0.160 | 21 | 46606442 | upstream gene variant | G/A | snv | 0.50 |
|
Mental Disorders | 0.020 | 1.000 | 2 | 2007 | 2011 | |||||||
|
0.732 | 0.160 | 21 | 46606442 | upstream gene variant | G/A | snv | 0.50 |
|
Mental Disorders | 0.020 | 1.000 | 2 | 2007 | 2011 | |||||||
|
0.851 | 0.200 | 21 | 46602317 | synonymous variant | C/A;G;T | snv | 0.65 |
|
Skin and Connective Tissue Diseases; Immune System Diseases | 0.010 | 1.000 | 1 | 2020 | 2020 | |||||||
|
0.851 | 0.200 | 21 | 46602317 | synonymous variant | C/A;G;T | snv | 0.65 |
|
Nervous System Diseases | 0.010 | 1.000 | 1 | 2018 | 2018 | |||||||
|
0.851 | 0.200 | 21 | 46602317 | synonymous variant | C/A;G;T | snv | 0.65 |
|
Nervous System Diseases | 0.010 | 1.000 | 1 | 2020 | 2020 | |||||||
|
0.851 | 0.200 | 21 | 46602317 | synonymous variant | C/A;G;T | snv | 0.65 |
|
Mental Disorders | 0.010 | 1.000 | 1 | 2011 | 2011 | |||||||
|
0.851 | 0.200 | 21 | 46602317 | synonymous variant | C/A;G;T | snv | 0.65 |
|
Infections; Nervous System Diseases | 0.010 | 1.000 | 1 | 2020 | 2020 | |||||||
|
0.882 | 0.080 | 21 | 46602608 | 5 prime UTR variant | G/A;T | snv |
|
Behavior and Behavior Mechanisms | 0.010 | 1.000 | 1 | 2009 | 2009 | ||||||||
|
0.882 | 0.080 | 21 | 46602608 | 5 prime UTR variant | G/A;T | snv |
|
Mental Disorders | 0.010 | 1.000 | 1 | 2009 | 2009 | ||||||||
|
0.882 | 0.080 | 21 | 46602608 | 5 prime UTR variant | G/A;T | snv |
|
Mental Disorders | 0.010 | 1.000 | 1 | 2009 | 2009 | ||||||||
|
0.882 | 0.080 | 21 | 46602608 | 5 prime UTR variant | G/A;T | snv |
|
Behavior and Behavior Mechanisms | 0.010 | 1.000 | 1 | 2009 | 2009 | ||||||||
|
1.000 | 0.080 | 21 | 46601141 | intron variant | C/A;G;T | snv |
|
Nervous System Diseases; Mental Disorders | 0.010 | 1.000 | 1 | 2007 | 2007 | ||||||||
|
1.000 | 0.040 | 21 | 46602974 | intron variant | A/G | snv | 9.4E-02 |
|
Mental Disorders | 0.010 | 1.000 | 1 | 2012 | 2012 | |||||||
|
0.732 | 0.160 | 21 | 46606442 | upstream gene variant | G/A | snv | 0.50 |
|
Neoplasms | 0.010 | 1.000 | 1 | 2011 | 2011 | |||||||
|
0.732 | 0.160 | 21 | 46606442 | upstream gene variant | G/A | snv | 0.50 |
|
Neoplasms | 0.010 | 1.000 | 1 | 2011 | 2011 | |||||||
|
0.732 | 0.160 | 21 | 46606442 | upstream gene variant | G/A | snv | 0.50 |
|
Neoplasms | 0.010 | 1.000 | 1 | 2011 | 2011 | |||||||
|
0.732 | 0.160 | 21 | 46606442 | upstream gene variant | G/A | snv | 0.50 |
|
Neoplasms | 0.010 | 1.000 | 1 | 2011 | 2011 | |||||||
|
0.732 | 0.160 | 21 | 46606442 | upstream gene variant | G/A | snv | 0.50 |
|
Neoplasms; Nervous System Diseases | 0.010 | 1.000 | 1 | 2011 | 2011 | |||||||
|
0.732 | 0.160 | 21 | 46606442 | upstream gene variant | G/A | snv | 0.50 |
|
Neoplasms | 0.010 | 1.000 | 1 | 2011 | 2011 | |||||||
|
0.732 | 0.160 | 21 | 46606442 | upstream gene variant | G/A | snv | 0.50 |
|
Neoplasms | 0.010 | 1.000 | 1 | 2011 | 2011 | |||||||
|
0.776 | 0.200 | 21 | 46599326 | 3 prime UTR variant | G/A | snv | 0.16; 2.4E-05 | 0.21 |
|
Behavior and Behavior Mechanisms | 0.010 | 1.000 | 1 | 2009 | 2009 | ||||||
|
0.776 | 0.200 | 21 | 46599326 | 3 prime UTR variant | G/A | snv | 0.16; 2.4E-05 | 0.21 |
|
Mental Disorders | 0.010 | 1.000 | 1 | 2009 | 2009 |